Premature Rupture of Membranes (PROM) Testing Market

Global Premature Rupture of Membranes (PROM) Testing Market was valued at USD 4.64 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a CAGR of 5.5% during the forecast period.

Rupture of membranes prior to the onset of labor is known as Premature Rupture of Membranes (PROM). PROM occurs in 8%-10% of all term pregnancies and in 2%-4% of all preterm singleton pregnancies, with approximately 3% of all pregnancies in the United States.

To Know About The Research Methodology :- Request Free Sample Report

The study provides a detailed perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ MN), across different geographies, which include North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM).

The report provides qualitative and quantitative insights on the premature rupture of membranes (prom) testing industry trends and detailed analysis of market size and growth rate of all segment in the market. The Global Premature Rupture of Membranes (PROM) Testing Market is segmented by Test, End User and Region.

Key players covered in the Global Premature Rupture of Membranes (PROM) Testing Market includes Abbott Laboratories, Biosynex, Cooper Surgical, Hologic, IQ Products, Medix Biochemica, Parsagen Diagnostics_Inc, Qiagen, Sera Prognostics.

Premature Rupture of Membranes (PROM) Testing Market Dynamics

Having either diabetes or high blood pressure during pregnancy doubled a woman's future risk of premature rupture of membranes (PROM). High blood glucose levels can be harmful during this early stage labor and can increase the chance that your baby will have birth defects, such as heart defects or defects of the brain or spine. For these reasons, the pregnant women prefers the PROM testing to reduce the future risks.

Advancement in technology and connectivity with point-of-care testing drives the premature rupture of membranes (PROM) testing market. Point-of-care PROM testing offers easier access for pregnant women at remote locations and other off site areas. Superior performance of easy to use rapid PROM test has revolutionized pregnancy monitoring for millions of women, which led to opportunity for global premature rupture of membranes testing market.

In 2025, the Biochemical Test segment shows the highest demand in the Premature Rupture of Membranes (PROM) Testing Market. These tests, including advanced immunoassay-based diagnostics, provide higher accuracy and faster results compared to traditional methods, making them widely adopted in hospitals and maternity centers. Among them, AmniSure Test, ROM Plus Test, and Actim PROM Test are increasingly preferred due to their ability to detect specific amniotic fluid biomarkers, improving diagnostic reliability and reducing false results. Traditional methods such as Nitrazine Test, Fern Test, and Pooling Test remain widely used due to their low cost and ease of use, particularly in smaller healthcare facilities. Ultrasound Test and Amnio-dye Test are typically used as confirmatory methods in complex cases, while Fetal Fibronectin Test is gaining importance in evaluating the risk of preterm labor associated with membrane rupture.

Based on End-User, Hospitals represent the largest and most demanded segment in 2025. Hospitals handle a high volume of obstetric emergencies and high-risk pregnancies, making them the primary centers for PROM diagnosis and management. Diagnostic Laboratories also play a significant role by conducting confirmatory biochemical tests and supporting hospitals with specialized diagnostic capabilities. Clinics and Maternity Clinics / Birthing Centers are increasingly adopting rapid PROM test kits to provide immediate diagnosis and timely referral when complications arise. Ambulatory Surgical Centers contribute moderately to the market by supporting obstetric procedures and prenatal care services. Meanwhile, Homecare Settings are emerging gradually with the availability of point-of-care diagnostic kits, although adoption remains limited due to the need for professional medical evaluation.

Premature Rupture of Membranes (PROM) Testing Market Scope: Inquire before buying

Premature Rupture of Membranes (PROM) Testing Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Key Players /Competitor Profiles Covered in the Premature Rupture of Membranes (PROM) Testing Market Report from a Strategic Perspective.

1. Abbott Laboratories
2. F. Hoffmann-La Roche Ltd
3. Siemens Healthineers AG
4. Danaher Corporation
5. Thermo Fisher Scientific Inc
6. Becton Dickinson and Company
7. Hologic Inc
8. QuidelOrtho Corporation
9. Sekisui Diagnostics
10. Medix Biochemica
11. Sera Prognostics Inc
12. NX Prenatal Inc
13. Clinical Innovations LLC
14. CooperSurgical Inc
15. PerkinElmer Inc
16. Bio-Rad Laboratories Inc
17. Randox Laboratories Ltd
18. Biomerieux SA
19. Arbor Vita Corporation
20. Acon Laboratories Inc
21. Creative Diagnostics
22. Atlas Medical GmbH
23. Response Biomedical Corp
24. EKF Diagnostics Holdings plc
25. DiaSorin SpA